Chapter 53: Acute & Critical Care Flashcards

1
Q

Crystalloid
- what is it + examples/ when to use it ?

A
  • contains various conc of sodium and / or dextrose
  • passes freely b/w semipermeable membranes. Volume does not remain in intravascular space (inside blood vessels) - however it moves into extravascular or interstitial space
  • cost less and with fewer AEs compared to Colloids
  • Exs:
    —- 5% Dextrose (contains free H2O and is used when H2O is needed intracellularly)
    —– Lactated Ringer’s and NS are most commonly used for volume resuscitation in shock state.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Colloids
- what is it/ examples + when to use it?

A
  • Large molecules (protiens or starch)
  • primarily remains in intravascular space (in blood vessels) and increases oncotic pressure.
  • MORE $$$ and no clear benefit over crystalloids
  • EXs:
    —— Albumin %5, 25% (Albutein, AlbuRX) -most common colloids, useful when there is significant edema (ie, cirrhosis). Albumin shouldnt be used for nutritional supp if albumin is low!
    —– Hydroxyethyl starch - only used if no other TX is available due to boxed warning for mortalitiy, renal injury, and coagulopathy (bleed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Electrolyte Disorder: Sodium (Hyponatremia): general/ the different types

A
  • Define as **Na < 135 mEq/L **
  • However, patient is usually not symptomatic until Na < 120!
  • Symp mostly result from cerebral edema and increases intracranial pressure and can range from mild/mod (HA, confusion, gait distrubances) to severe (SZ, coma, death!)
  • Include difference classifications: hypotonic hypervolemic hyponatremia, hypotonic isovolemic hyponatremia, hypotonic hypovolemic hyponatremia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Electrolyte Disorder: Sodium (Hyponatremia)

Why should hyponatremia not be corrected too quickly?

A

Correction goal is only 4-8 mEq/L/24hrs! Correcting Na more rapidly than 12mEq/L/24hrs can cause osmotic demyelination syndrome (ODS) or central pontine myelinolysis (which can cause paralysis, SZ, death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Electrolyte Disorder: Sodium (Hyponatremia)

Hypotonic hypervolemic hyponatremia: causes and treatment?

A
  • Causes: fluid overload (ie. HF, renal failure, cirrhosis )
  • TX: Diuresis with fluid restriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Electrolyte Disorder: Sodium (Hyponatremia)

Hypotonic Isovolemic Hyponatremia: causes and treatment?

A
  • Causes: syndrome of inappropriate antidiuretic hormone (SIADH)
  • TX: Diuresis, fluid restriction, and stopping drugs that can cause SIADH)… Demeclocycline can be used off-label for SIADH!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Electrolyte Disorder: Sodium (Hyponatremia)

Hypotonic Hypovolemic Hyponatremia: causes and treatments?

A
  • Causes: diuretics, salt-wasting syndromes, adrenal insuff., blood loss, or V/D
  • Treatment: correct the underlying causes. patient with acute hyponatmia, severe sympts, or Na below 120? can use **Hypertonic 3% NaCL IV **
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Electrolyte Disorder: Sodium (Hyponatremia)

The use of arginine vasopressin (AVP) receptor antagonists?

A
  • Ex of drugs: conivaptan and **tolvaptan **
  • may be used to treat SIADH and hypervolemic hyponatremia
  • MOA: increase excretion of H2O while maintaining sodium
  • role TBD… more expensive than just using 3% NaCL and you cannot use the oral product (tolvaptan) for more than 30 days!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Electrolyte Disorder: Sodium (Hyponatremia)

Arginine Vasopressin Receptor Antagonist: Conivaptan
- brand
- doses
- contraindications
- warning
- SE
- monitoring

A
  • brand: Vaprisol
  • doses: LD 20mg IV over 30 mins and MD 20mg IV over 24 hrs (avoid use in CrCL less than 30
  • contraindications: hypovolemic hyponatremia, strong CYP4A4 inhibitors
  • warning: over rapid correct of Na = ODS!
  • SE: orthostatic hypotension, fever, hypokalemia, infusion rxn site
  • monitoring: rate of Na increase, BP, volume, urine output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Electrolyte Disorder: Sodium (Hyponatremia)

Arginine Vasopressin Receptor Antagonist: Tolvaptan
- brand
- doses
- boxed warning
- contraindications
- warning
- SE
- monitoring

A
  • brand: Samsca
  • doses: 15mg po QD (max 60mg po qd) limit use to less than 30 days due to hepatox! avoid if CrCl is less than 10
  • boxed warning: initiated/ reinitated only at hospital, rapid correct of Na can = ODS!
  • contraindications: hypovolemic hyponatremia, strong CYP4A4 inhibitors, ppl unable to sense or respond to thirst
  • warning: hepatox
  • SE: thirst, N, dry mouth, polyuria, hyperglycemia, hypernaturemia
  • monitoring: rate of Na increase, BP, volume, urine output, signs of hepatox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Electrolyte Disorder: Sodium (Hypernatremia): general, causes, types

A
  • **Na > 145 mEq/L **! associated with water deficit and hypertonicity
  • Hypovolemic hypernatremia: dehydration, V/D - treated with fluids
  • Hypervolemic Hypernatremia: intake of hypertonic fluids - treated with diuresis
  • Isovolemic Hypernatremia: diabetes insipidus, which can decrease antidiuretic hormones (ADH), treated with desmopressin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Electrolyte Disorder: Potassium K+ (hypokalemia)

Electrolyte Disorder: Potassium K+ (hypokalemia)
- general
- management
- 10 mEq will raise serum K+ by how much?

A
  • hyperkalemia is often due to CKD!
  • hypokalemia < 3.5 mEq/L (common in hospitalized patients)
  • a drop of 1 mEq/L below 3.5 mEq/L represents a total body deficit of 100-400 mE!
  • Management: treat underlying causes (ie. metabolic alkalosis, overdiuresis, meds like insulin and amphotericin, and admin of IV or oral K+
  • 10 mEq of k+ increases the K+ serum level by 0.1 mEq
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Electrolyte Disorder: Potassium K+ (hypokalemia)

IV Potassium Replacement
- what is the most common solution used?
- conc and rate?
- K+ relationship with Mg+?

A
  • Potassium Chloride (KCl) IV solution is generally used.
  • Safe recc: peripheral line with max infusion rate of < 10 mEq per hour and max conc. of 10 mEq/100mL (although higher infusion rate/ conc may be needed for severe or symptomatic hypokalemia = these also require central line! and cardiac monitoring!)
  • Can be fatal if admin. undiluated or via IV push
  • Magnesium is needed for optimal Potassium uptake! so you may need to check Mg+ serum if hypokalemia is resistent to tx! Mg+ should be replaced first if both hypoK+ and hypoMg+ is presented
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Electrolyte Disorder: Magnesium Mg+ (hypomagnesemia)

Electrolyte Disorder: Magnesium Mg+ (hypomagnesemia)
-general
-when to use IV vs oral? replacement?

A
  • More common than hyperMg+! (hyper is more due to renal insuff.)
  • HypoMg+ = < 1.3 mEq/L
  • Causes : chronic alcohol use, diuretics, ampB, V/D
  • when Mg+ serum is < 1 WITH life threatening symp like SZ, arrhythmias … IV Magnesium Sulfate is recc.
  • Mg+ serum 1-1.5? orally replacement reccomended (Mg oxide for ~5 days)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Electrolyte Disorder: Phosphorus (hypophosphatemia)

Electrolyte Disorder: Phosphorus (hypophosphatemia)
- general
- causes
- tx?

A
  • HyperPhos is usually due to CKD
  • HypoPho is considered severe and usually symptomatic (< 1 mE/dL)
  • symptoms: muscle weakness, respiratory failure
  • Causes: phosphate binding drugs (ie. calcium salts, sevelamer), chronic alcohol use, hyperthyroidism
  • TX: when <1 ? IV! 0.08-0.16 mmol/kg in 500mL usually reccomended
  • patients with hypophos typically have hypoK+ and hypoMg+ as wellso those will need to be corrected as well!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Other TX in hospitalized patients

Incentive Spirometry: what is it/ uses

A
  • a technique used to facilitate lung expansion in patient with atelectasis (complete or partially collapsed lung w/ reduced lung volume)
  • Atelectasis is a common complication especially in post op patient. It can lead to retained airway secretion, dyspnea, hypoxemia, and other pulm. complications.
  • Incentive Spirometer is a device that facilitate deep breathing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Other TX in hospitalized patients

IV Immunoglobulin: what is it/ uses

A
  • contains IgG (extracted from plasma of many blood donors)
  • Given as plasma protein replacement tx for immune def patients who have decreased antibodies production capabilities.
  • only used for immuno def conditions! and other off lable uses including: multiple sclerosis, myasthenia gravis, Guillain-Barre syndrome
  • can impair responses to vaccines!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Other TX in hospitalized patients: IV IgG

IV Immunoglobulin
- brand
- boxed warning
- contraindication
- warnings
- Ses
- Monitoring
- Notes

A
  • brand: Gammagard, Gamunex-C, Octagam, Privigen
  • boxed warning: acute renal dysfunction can occur altho rare!; it usually occurs within 7 days (more likely with products stabilized with sucrose)
  • contraindication: IgA deficiency
  • warnings: use w/ caution in CV disease
  • SEs: HA, n/d, inj site rxn, infusion rxn (flushing, fever, chest tightening, hypotension - stop or slow infusion!), renal failure
  • Monitoring: renal func, urine output, volume status, HbG
  • Notes: slower tritration/ premed. may be needed if patient had rxn in past !
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the scoring tool used to determine ICU mortality risk?

A

The Acute Physiologic Assesment and Chronic Health Evaluation II (APACHE II)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ICU medications that target the sympathetic nervous system

Vasopressors : effects on alpha and beta?

A
  • Work by stimulating Alpha receptors; causing peripheral vasoconstruction and increases systemic vascular resistence (SVR), which increases blood pressure (BP)
  • Vasopressors that stimulate Beta receptors can increase heart rate and cardiac output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Vasopressor Drugs: ICU medications that target the symp nervous sys

1.) Dopamine
- MOA

A

Dose dependent!
- low (renal) dose: 1-4mcg/kg/min: dopamine 1 agonist
- medium dose: 5-10mcg/kg/min: Beta 1 agonist
- High dose: 10-20mcg/kg/min: Alpha 1 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vasopressor Drugs: ICU medications that target the symp nervous sys

2.) Epinephrine
- MOA
- brands
- notes

A
  • Brands: Adrenalin, Epipen
  • Alpha 1agonist , Beta 1 and 2 agonist
  • used for push IV is 0.1mg/mL (1:10,000 ratio strenght); for IM inj or compounding is 1mg/mL (1:1,000)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Vasopressor Drugs: ICU medications that target the symp nervous sys

3.) Norepinephrine
- brand
- MOA

A
  • Brands: Levophed
  • Alpha 1 agonist > Beta 1 agonist activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Vasopressor Drugs: ICU medications that target the symp nervous sys

4.) Phenylephrine
- MOA

A
  • Alpha 1 agonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Vasopressor Drugs: ICU medications that target the symp nervous sys

5.) Vasopressin
- Brand
- MOA

A
  • Brand: Vasostrict, also know as AVP and ADH!
  • Vasopressin receptor agonist = vasoconstrictor with no inotropic or chronotropic effects
26
Q

Vasopressor Drugs: ICU medications that target the symp nervous sys

Safety/ SEs/ Monitoring of all vasopressors
- boxed warnings
- warnings
- SEs
- Monitoring
- Notes

A
  • boxed warnings: Dopamine and NorEpi have box warning for extravasation - treat with phentolamine, all vasopressors are vesicants (causes blistering/ irritation!)
  • warnings: used with extreme caution in patient taking MAO inhibitors; prolong hypertension may occur (dopamine, Epi, Norepi)
  • SEs: arrhythmias, tachycardia (dopamine, epi, norepi), necrosis, bradycardia (phenylepi), hyperglycemia (epi)
  • Monitoring: BP, HR, mean arterial pressure (MAP), ECG, urine output, infusion site for extravasation
  • Notes: Don’t use if they discoloration/ percipitation!, all are Y-site compatible with each other except angiotensin II), admin via central IV line!
27
Q

Vasopressors: ICU medications that target the symp nervous sys

Extravasation

A

Many drugs used in ICU are vesicants that causes severe tissue damage/ necrosis with extravasation (leakage of drug from blood vessel into surrounding tissues)- this is a medical emergency!!!. To reduce risk, every atempt should be made to infuse vasopressors through a central line! Vasopressor extravasation should be treated with phentolamine (an alpha 1 blocker that antiagonizes effects of vasopressor ). If extravasation occurs with norepi, epi, or phenylepi, d/c infusion but do not disconnect line or flush - gently remove drug instead!

28
Q

ICU medications that target the sympathetic nervous system

Vasodilators

A
  • vasodilators admin via IV infusion include nitroglycerin and nitroprusside
  • Nitroglycerine is often used when ther’s active myocardial ischemia or uncontrolled HTN (but effectiveness may be limited to 24-48hrs due ti tachycardia)
  • Nitroprusside is a mixed/ equal arterial and venous vasodilator at all dose! Greater effect on BP than nitroglycerine. SHOULD NOT be used in active myocardial ischemia b/c it can cause blood to be diverted away from the diseased coronary arteries (coronary steal)
29
Q

Vasodilator:ICU medications that target the sympathetic nervous system

Toxicity of Nitroprusside

A
  • metabolism of nitroprusside results in thiocyanate (can cause tox in patient with renal insuff) and cyanide formation (can cause tox in patient with hepatic insuff)
  • reduce risk of thiocynate tox or to treat cyanide tox: hydroxocobalamin
  • treat cyanide tox: **sodium thiosulfate + sodium nitrite **
30
Q

Vasodilator: ICU medications that target the sympathetic nervous system

Nitroglycerin
- MOA
- Contraindication
- Warning
- SEs
- Monitoring
- Notes

A
  • MOA: low doses - venous vasodialator, high doses - arterial vasodilator
  • Contraindication: SBP < 90, concurrent use w/ PDE5 inhibitors or riociguat
  • Warning: severe hypotension and increased intracranial pressure
  • SEs: HA, tachycardia, tachyphylaxis
  • Monitoring: HR, BP
  • Notes: requires non-PCV container (ie. glass)
31
Q

Vasodilator: ICU medications that target the sympathetic nervous system

Nitroprusside
- MOA
- Boxed warning
- Warning
- SEs
- Monitoring
- Notes

A
  • MOA: equal arterial/ venous vasodilator
  • Boxed warning: metabolism produces cyanide! so use lowest dose at shortest duration! Excessive hypotension to monitor BP closely, no direct injection (must be diluted!)
  • Warning : increase intracranial pressure
  • SEs: HA, tachycardia, thiocyanate/ cyanide tox
  • Monitoring: HR, BP, renal and hep function, urine output
  • Notes: need light protection! do not use if blue in color (indicates degradation to cyanide)
32
Q

Inotropes: ICU medications that target the sympathetic nervous system

What does inotropes do/ examples of some inotropes

A

IV inotropes increases the contractility of the heart.
-** Dobutamine **is a beta-1 agonist that increase HR and force of myocardial contraction, which increase cardiac output (CO). It has weak beta-2 (vasodilation) and alpha 1 agonist activity
- Milrinone is a selective phosphodiesterase-3 inhibitor in cardiac and vascular tissue. It produces inotropic effects with significant vasodilation

These agents should only be used whne BP is adwquate becuase they produce vasodilation!

33
Q

What is shock define as? What are the different types of shocks?

A

Shock is a medical emergency common in ICU patients. Characterized by hypoperfusion, usually in the setting of hypotension (defined as SBP < 90 mmHg or MAP < 70 mmHg.

There are 4 main types of shock:
1. Hypovolemic (ie. bleed/ hemorrhagic)
2. Distributive (ie. septic, anaphylactic)
3. Cardiogenic (ie. post myocardial infarction)
4. Obstructive (ie. PE)

Diagnosis of shock is based on hemodynamic parameters and more than one type of shock can occur at the same time.

34
Q

Shock

Hypovolemic Shock: Treatment

A

Replenish what is loss! Restore intravascular volume to mprove O2 carrying capacity.
1.) non-hemorrhagic hypovolemic shock: fluid resuscitation with crystalloids
2.) hemorrhagic/ bleeding hypovolemic shock: blood products (packed RBC, fresh frozen plasma)

If the patient does not respond to inital fluid or blood product.. they are considered “fluid challenge” and vassopressors may be indicated (keep in mind that vasopressors may not be effective unless intravascular volume is adequate).

35
Q

Shock

Distributive Shock: characterized/ different causes?

A

characterized by low SVR, and initially high CO followed by low or normal CO. Septic, anaphylactic and neurogenic shock are example of distributive shock

36
Q

Distributive Shock

Sepsis and Septic Shock: define, causes, general tx

A

Define as life threatening oxygen dysfunction caused by dysregulated host response to infection. NEWS and SIRS criteria are used to evaluate sepsis. General TX: MAP should be 65 or above! (MAP=[2*DBP + SBP]/3)

We want to optimize preload with IV crystalloids (balanced fluids like LR is preferred). We may then use alpha 1 agonist to promote vasoconstriction to increase SVR and Beta 1 agonist to increase myocardial contractility and CO

Septic shock is sepsis with persistent hypotension requiring vasopressor to maintain MAP of 65 or above and serum lactate level of 2 meq/L or greater DESPITE FLUID RESUSCITATION

37
Q

Septic Shock (Distributive Shock)

The Surviving Sepsis Campaign: general treatment

A

An intiative that prompts the use of selected evidence based interventions called bundles o reduce mortality from sepsis and septic shock. These bundles include administering of broad spectrum ABX and fluid resuscitation with IV crystalloids. If perfusion cannot be maintained by fluids… vasopressor is considered with Norepi being the vasopressor of choice for septic shock! Then Vasopressin is commonly used in addition to norepi

38
Q

Septic Shock

What are the two most common causes of ICU infections?

A

1.) Mechanical Ventilation: pushes air Into the lungs for patients who cannot breathe on their own. Air flows into the trachea through an endotracheal tube (ET tube) placed through the mouth or nose. This is called intubation. “Weaning ‘ refers to the process of getting the patient off the ventilator, when they are ready to breathe on their own again… increased time on ventilator = increase risk of infection! B/C pseudomonas (and a few other organisms) thrive in the moist air in the ventilator!
2.) Foley catheters: a common type of Indwelling urinary catheter. Intubated patients have an indwelling catheter that is inserted into the bladder to drain urine. Foley catheters are the most common type! increased risk of bladder infection!

39
Q

Cardiac Shock

ACUTE DECOMPENSATED HEART FAILURE AND CARDIOGENIC SHOCK: General and clinical presentation

A

Heart failure patients may go through periods of worsening symptoms, referred to as acute decompensated heart failure (ADHF). These symptoms include sudden weight gain, difficulty lying flat without experiencing shortness of breath, reduced functionality in performing daily tasks, increased shortness of breath, and fatigue. If the condition is accompanied by low blood pressure (hypotension) and inadequate blood flow (hypoperfusion), it is termed cardiogenic shock.

ADHF is caused by worsening HF due to cardiac event (MI, arrthy, uncontrolled HTN) or non cardiac events (non-adhere to meds or diet restriction, worsening renal, or infection). Negative inotropic drugs (non-DHP CCBs), drugs that causes fluid retention (NSAID) and cardiotox drugs may worsen cardiac function/ exacerbate HF!

ADHF presents with volume overload, hypoperfusion or both. Some patient requires monitoring w/ a catheter that is guided through the right side of the heart into the pulmonary artery called Swan-Ganz. The catether provides hemodynamic measurements of congestion (pulm capillary wedge pressure), hypoperfusion (cardiac output), and other measurements (SVR, CVP) useful for guiding TX. **Beta blocker should be stopped in an ADHF if hypotension aor hypoperfusion is present! **

40
Q

ACUTE DECOMPENSATED HEART FAILURE AND CARDIOGENIC SHOCK: Presentation and Treatment for Volume Overload patients.

A

ADHF most commonly presents with volume overload.
Volume overload is treated with diuretics and possibly IV vasodilators. Loop diuretics are initially given IV since volume overload also affects the vessels of the gut and can decrease their oral absorption . If diuretic resistance develops, the dose can be increased or a thiazide-type diuretic (e.g., metolazone, chlorothiazide) can be added to the loop.

Presentation: patients with edema, juglar venous distension and/ or ascities are VOLUME OVERLOAD. TX: loop diuretics and vasodilators can be added (NTG, nitroprusside)

41
Q

ACUTE DECOMPENSATED HEART FAILURE AND CARDIOGENIC SHOCK: Presentation and Treatment for hypoperfusion patients.

A

The most common cause of cardiogenic shock {or ADHF with hypoperfusion) is myocardial infarction (MI) with resulting failure of the left ventricle. Cardiogenic shock requires treatment with vasopressors and/or inotropes. The vasodilatory and inotropic properties of** dobutamine** and** milrinone** make them uniquely suited to treating ADHF in patients with both congestion and hypoperfusion when BP is adequate. If BP is inadequate, inotropes will often be used in combination with vasopressors (phenylephrine, norepi, dopamine). Inotropes are associated with worse outcomes in heart failure and should be stopped as soon as the patient is stabilized.

42
Q

Other Common ICU Condition

Pain: general and treatment/ approach

A

IV opioids like morphine, hydromorphone, and fentanyl are the first choice for pain management in the ICU. The choice of opioid depends on the drug’s properties and the patient’s kidney and liver function, as all IV opioids have similar pain-relieving effects when properly dosed. Additional medications like acetaminophen and NSAIDs may be used depending on the type of pain. Pain assessment using validated scales should be done every 2-4 hours, and all ICU patients should be evaluated for pain at rest. “Analgosedation,” a sedation strategy that prioritizes pain relief to reduce agitation, leads to less time on ventilators and shorter ICU stays.

43
Q

Other Common ICU Conditions

Agitation: general, treatment and approach

A

Sedation in the ICU is necessary to ensure synchronized breathing with the ventilator and alleviate suffering in the intense environment. Agitation is managed using benzodiazepines (lorazepam, midazolam) and/or non benzo hypnotics (propofol, dexmedetomidine). Non-benzodiazepines like propofol and dexmedetomidine are preferred for sedation due to better ICU outcomes, shorter mechanical ventilation duration, and reduced length of stay. Dexmedetomidine (Precedex) is the only sedative approved for both intubated and non-intubated patients. However, benzodiazepines remain essential for sedation in cases of seizures or alcohol/benzodiazepine withdrawal.

44
Q

Agitation

Sedation: scales and management

A

Sedatives are used with validated sedation scales that allows for titration to light sedation (preferred) to deep sedation. Common sedation scale include: Richmond Agitation Sedation Scale RASS, Ramsay Agitation Scale RAS, and the Riker Sedation Agitation Scale SAS. The Glasgow Coma Scale determine the level of conciousness (often after a trama brain injury). Sedated patients should be monitor q 2-3hours to make sure they are receiving the least amount of drug to keep them calm and pain free. Daily interruptions (“sedation vacation”) of continuous sedative infusions are used to assess readiness to wean off/ stop sedative ASAP.

45
Q

RICHMOND AGITATION AND
SEDATION SCALE (RASS)

A
46
Q

Other Common ICU Conditions

Delirium: general/ treatment/ approach

A

Delirium affects a significant number of ventilated ICU patients (up to 80%) and is linked to higher mortality and longer stays in the ICU. Regular delirium assessment is essential. Reducing delirium incidence is possible through early mobilization and controlling the patient’s environment (e.g., managing light, noise, and stimuli). Preventive medications are not recommended. Using non-benzodiazepine sedation may help decrease delirium occurrence or duration in patients already affected. The evidence supporting haloperidol for treating ICU delirium is limited, despite its common use. Atypical antipsychotics, particularly quetiapine (mildly sedating with low risk for movement disorders), can be helpful.

47
Q

Pain medication used in crit care

List the common pain medications used in crit care/ ICU and their properties

A
48
Q

agitation/sedation medications

List the common agitation/sedation medications used in crit care/ ICU and their properties

A

1.) Dexmedetomidine (Precedex): Alpha-2 adrenergic agonist, SE: Hypo/hypertension, bradycardia, dry mouth, nausea, constipation; Duration of infusion should not exceed 24 hours per FDA labeling,
Used for sedation in intubated and non-intubated patients
2.) Propofol (Diprivan): Short-acting general
anesthetic; SE: Hypotension, apnea, hypertriglyceridemia, green urine/hair/nail beds, propofol-related infusion syndrome (PRIS -
rare but can be fatal), monitor TG!; Use strict aseptic technique due to potential for bacterial growth . Discard vial and tubing within 12 hours of use.
3.) Lorazepam (Ativan) - Benzo, Injection is formulated in propylene glycol; total daily dose as low as 1 mg/kg/day can cause propylene glycol toxicity
(acute renal failure and metabolic acidosis)
4.) Mldazolam (Versed): Benzo, dont use with a, use with potent CYP3A4 inhibitors (contraindication), Can accumulate in obese patients (highly lipophilic) and renal impairment (active metabolite) - caution with
continuous infusion
5.)Etomidate (Amidote): Nonbarbiturate hypnotic
Ultra short-acting; used as an induction agent for intubation; Monitor for adrenal insufficiency (hypotension, hyperkalemia)
6.) Ketamine (Ketalar); NMDA receptor antagonist; can cause Emergence reactions (vivid dreams, hallucinations , delirium) hypotention

49
Q

Other Common ICU Conditions

Stress Ulcers: patho/general, treatment

A

Stress ulcers can occur in ICU patients due to the metabolic stress they experience. Critical illness leads to reduced blood flow to the gut as blood is redirected to vital organs, causing the breakdown of gastric mucosal defense mechanisms, such as prostaglandin synthesis, bicarbonate production, and cell turnover.
Histamine-2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) are recommended for preventing stress-related mucosal damage** in patient with risk factors.** However, H2RAs may cause thrombocytopenia and mental changes in the elderly or those with renal/hepatic issues, and tachyphylaxis (tolerance) has been reported. PPIs have been linked to higher risks of GI infections (C. difficile), fractures, and nosocomial pneumonia. Stress ulcer prophylaxis should not be given to patients without risk factors.

50
Q

RISK FACTORS FOR THE DEVELOPMENT

Stress Ulcers: Risk factors

A

Mechanical ventilation > 48H
Coagulopathy

Sepsis
Traumatic brain injury
Major burns
Acute renal failure
High dose systemic steroids

51
Q

Additional drugs used in ICU and operation rooms

Anesthetics: general, how they work, purpose, important things to note

A
  • Anesthetics serve different purposes, such as numbing (local anesthesia), blocking pain (regional anesthesia), or inducing temporary loss of consciousness during surgery (general anesthesia). They can be administered through various methods, including topical application, inhalation, intravenous, epidural, or spinal routes.
  • Anesthetics are increasingly combined with opioids to reduce the need for opioids in pain control. They work by blocking nerve impulses through reduced sodium permeability. Continuous monitoring of vital signs and respiration is essential during anesthesia administration. Common side effects include hypotension, bradycardia, nausea, vomiting, and mild drop in body temperature leading to shivering. Overdose can cause respiratory depression, and allergic reactions are possible. Inhaled anesthetics may rarely trigger malignant hyperthermia. Caution is necessary with bupivacaine in epidurals, as intravenous administration can be fatal. Lidocaine should not be given through both intravenous and topical routes simultaneously. Lidocaine/epinephrine combinations are used for localized numbing in specific procedures, but confusion with epinephrine products can lead to serious consequences. Always ensure the correct product, concentration, and administration route are used.
52
Q

Additional drugs used in ICU and operation rooms

Commonly used anesthetics and how they are given

A

1.)** Local **- lidocaine (Xylocaine), benzocaine, liposomal bupivacaine (Exparel)
2.) Inhaled - desflurane (Suprane), sevoflurane (Ultane), isoflurane (Forane), nitrous oxide , others
3.) Injectable - bupivacaine (Marcaine, Sensorcaine), lidocaine (Xylocaine), ropivacaine (Naropin), other s

53
Q

Additional drugs used in the ICU and operation rooms

Neuromuscular Blocking Agents (NMBAs)

A

Patients can require the use of NMBAs in surgery conducted under general anesthesia to facilitate mechanical ventilation, to treat muscle spasms (tetany) or to prevent shivering when undergoing therapeutic hypothermia after cardiac arrest. NMBAs are used when other methods are ineffective (not first line). NMBAs causes paralysis f the skeletal muscle, including those for respiration (eg. the diaphram), and patients must be mechanically ventilated. NMBAs also have no effect on pain or sedation, patients should recieve adequate sedation and pain med prior to starting NMBA. NMBAs are considered high risk and should have auxiliary label “warning: paralyzing agent”. There are 2 types of NMBAs: depolarizing and non-depolarizing.

54
Q

NMBAs: depolarizing: general, safety, SEs, monitoring

A

Succinylcholine is the only avalible depolarizing agent; resembling acetylcoline (ACh), succinylcholine binds to and activates the ACh receptors and desensitize them. It’s typically reserve for intubation and is not used for continuous neuromusc blockade. This drug is associated with causing malignant hyperthermia. Succ. is also short acting with fast onset of action (30-60 secs)

55
Q

NMBAs: non-depolarizing: general, safety, SEs, monitoring

A

Non depolarizing NMBAs works by binding to ACh receptor an blocking the actions of endogenous ACh. For all non depolarizing NMBA, SEs: flushing, bradycardia, hypotension,. tachyphylaxis. Monitoring: BP, HR, peripheral nerve stimulation.
Drug examples:
1. Pancuronium - long acting; can accumulate in renal/ hepatic dysfunction; increase HR
2. Rocuronium - intermed acting
3. Vecuronium - intermed acting
4. Cisatracuronium and 5. Atracurium - short t1/2; intermed acting; metabolize by Hofmann Elimination (indep of renal or liver function!)

56
Q

Special consideration for patients on NMBAs

A

Patients recieving NMBAs are unable to breathe, move, blink, or cough. Special care must be taken in order to protect the skin, lub the eyes, and suction the airway. Glycopyrolate is an anticolinergic drug (“dry as bone/ blind as bat!”) that can be used to reduce secretions. Numerous meds can enchance the neuromusc blocking activity of NMBAs leading to toxicity! (ie. aminoglycosides, polymyxins, CCB, lithium, cyclosporins, vancomycin, quinidine)

57
Q

Other drugs used in ICU/ Crit Care

Hemostatic Agents

A

The term hemostasis means causing bleeding to stop. A variety of hemostatic methods can be used, ranging from simple manual pressure with one finger to electrical tissue cauterization, or the systemic administration of blood products (transfusions)
or hemostatic agents. The systemic hemostatic drugs work by inhibiting fibrinolysis or enhancing coagulation. Several factor products are available to treat hemorrhage in patients with hemophilia or rare factor deficiencies (FEIBA, Coagadex, Adynovate). Some hemostatic drugs (e.g., Praxbind, Andexxa) have been approved as reversal agents for specific anticoagulants. There are many topical hemostatic agents and most are used surgically. These include thrombin in bandages, liquids and spray forms, fibrin sealants, acrylates and a few others (names often include “throm”: Recothrom, Thrombin-JMI, Evithrom). A few topical hemostatics are OTC.

58
Q

Hemostatic Agents

Aminocaproic Acid (Amicar) (tablet, solution. inj): Safety, monitoring, SEs

A

Contraindications: Disseminated intravascular coagulation (wihtout heparin), active intravascular clotting process.
SEs: inj site rxn, thrombosis
Note: FDA approved for excessive bleeding associated with cardiac surgery, liver cirrhosis, and urinary fibrinolysis. DO NOT use in patients with active clots, and do not give with factor IX comlex concentrates due to increase risk of thrombosis!

59
Q

Hemostatic Agent

Tranexamic Acid (TXA): inj (Cyklokapron) and tablet form (Lysteda); SE, monitoring, Notes

A

Contraindication: IV form; acquired defected color vision, active intravascular clotting, subarachnoid hemorrhage
Oral form: previous or current thromboembolism disease, use with hormonal contraceptives
SE: Injection: vascular occlusion, thrombosis
Oral: retinal clotting
NOTE: oral TXA is approved for heavy periods (menorrhagia). The inj is approved for bleeding with hemophilia and is often used off lable to control surgical bleeding and trauma associated hemmorrhages

60
Q

Hemostatic Agents

Recomb Factor VIIa (NovoSeven RT): inj; SE, monitoring, notes

A

Boxed warning: risk of thrombotic events (particularly when used off lable)
NOTE: FDA approved for hemophilia and factor VII deficiency; has been used successfully off lable for patients with hemorrhage from trauma and warfarin related bleeding events